
pmid: 23814549
pmc: PMC3692186
Ghost cells have been a topic of controversy since a long time. The appearance of these cells in different lesions has given it varying terms. In lesions like that of Calcifying cystic odontogenic tumor (CCOT), these cells have been termed as 'Ghost cells' whereas similar descriptive cells have been called shadow/translucent cells in non-odontogenic lesions like Craniopharyngiomas of the pituitary gland and Pilomatricomas of skin. Controversy arises because of the fact that there are varying opinions and incomplete knowledge about their origin, nature, significance and relation in different neoplasms. Irrespective of the origin, these cells are seen in odontogenic and non-odontogenic neoplasms, which probably direct us towards a missing link between these differing neoplasms. This article attempts to present a review on the concepts around these peculiar cells and shed some light on these ghosts that are still in dark.
wnt pathway, odontogenic cyst, odontogenic tumor, Dentistry, shadow cell, notch pathway, RK1-715, pilomatricoma, ghost cell, Craniopharygioma
wnt pathway, odontogenic cyst, odontogenic tumor, Dentistry, shadow cell, notch pathway, RK1-715, pilomatricoma, ghost cell, Craniopharygioma
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 16 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
